Skip to content

Clinical trials

Phase 3 Muscular Dystrophy, Duchenne trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophy, Duchenne Phase: Phase 3 Country / region: Switzerland Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20132
20141
20161
20182
20203

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Santhera Pharmaceuticals3
PTC Therapeutics2
University Hospital, Basel, Switzerland2
Kyntra Bio1
Pfizer1
Sarepta Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophy, Duchenne10
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Muscular Diseases2
Muscular Disorders, Atrophic2
Muscular Dystrophies2
Musculoskeletal Diseases2
Nervous System Diseases2
Neuromuscular Diseases2
Respiratory Aspiration1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.